Fifth Annual Meeting April 15, 2016
The fifth annual meeting of the HighGlycan consortium was organized on April 15, 2016 in Dubrovnik, Croatia. All beneficiaries were represented. Highlights of the meeting were (1) the update on the Glycomics Methods Comparison study presented at the previous annual meeting, (2) brainstorming session on the further dissemination and outreach activities as well as the future of high-throughput glycomic technology within the HighGlycan consortium and beyond. Of note, several research groups of the HighGlycan consortium will prolong their collaboration for the study of the glycobiology of colorectal cancer within a project that recently received funding by the European Union, applying the technology developed within HighGlycan.
Fourth Annual Meeting October 6, 2015
The HighGlycan annual meeting was hosted by Dr. Daniel Kolarich and took place at the Free University Berlin in Berlin-Dahlem. At the meeting two developments of the HighGlycan consortium became apparent, which was a move towards biomedical and biopharmaceutical applications of the developed methods, as well as a comparison and evaluation of the developed key technologies on select application fields, to highlight the comparability of the obtained results as well as the strengths and limitations of the different glycoanalytical technologies.
Third Annual Meeting, September 10-11, 2014
The HighGlycan consortium got together in Leiden on September 10 and 11, 2014 for the third annual meeting. The progress of the research was discussed in the presence of Professor Jasna Peter-Katalinic, an expert in the field of biological mass spectrometry, mapping and sequencing of glycoconjugates and separation methods for ESI and MALDI MS. She was invited by the EU to act as a reviewer of the HighGlycan project. She liked the good quality of the data and the possibilities for collaboration within the project. At this stage of the project more results become available and the reviewer advised to make sure that there is a good interaction between researchers and clinicians.
After the annual meeting, in the afternoon of September 11 a series of lectures was being organized, together with the FP7 consortium IBD-BIOM. The presentations were focussed on the theme ‘Glycosylation, Antibodies and Inflammation’.
Second Annual Meeting, October 2-3, 2013
On October 2-3, 2013 the second annual meeting of the HighGlycan consortium took place in Split, Croatia. As was shown in the presentations, a lot of work has been done and research activities are going well. This is mirrored in the fact that the EC has approved the 18 month report of the consortium.
The HighGlycan partners find it important to collaborate with other consortia that focus on research topics closely related to the topics HighGlycan is dealing with. Therefore, after the HighGlycan annual meeting a joint training course was organized with another EU-project, MIMOmics (“Methods for integrated analysis of multiple omics datasets”). The participants of both consortia felt that is was very useful to discuss joint issues.
The next annual meeting for HighGlycan is scheduled for September 10-11, 2014 in Leiden and will be followed by a joint meeting with the EU-project IBD-BIOM.
Progress meeting: March 19, 2013
The members of the HighGlycan consortium met in Berlin on March 19, 2013 to discuss their activities. It was a fruitful meeting where not only senior researchers gave lectures but where also quite a lot of PhD-students had the opportunity to present their latest findings.
Progress meeting: November 2-3, 2012
The HighGlycan consortium got together on November 2, 2012 in Edinburgh to discuss the progress of the project. All participants gave an update on their work, points of interest were raised and future activities and milestones were discussed. So far the work is going according to schedule.
First Annual Meeting: May 30-31, 2012
The first annual meeting for HighGlycan took place in Split, Croatia, on May 30-31, 2012. The meeting started with presentations from members of the Industrial Impact Board (IIB). The IIB Board will make sure that technology development in HighGlycan will meet the needs of the biotechnology and pharmaceutical industry in the EU. Subsequently the work progress was discussed. In a pleasant and open atmosphere, PI’s, post-docs and students presented their work and discussed in detail the results so far, topics that needed some extra attention and the planning for the next year. The members of the consortium look back at a successful and motivating meeting.
The HighGlycan consortium started 1st November 2011. It brings together four industrial and four academic partners in developing high-throughput glycosylation analysis technology for both academic and industrial applications.
The Kickoff meeting has taken place on 15th and 16th December in Leiden, The Netherlands.